Authors:
LOCK EA
ELLIS MK
GASKIN P
ROBINSON M
AUTON TR
PROVAN WM
SMITH LL
PRISBYLLA MP
MUTTER LC
LEE DL
Citation: Ea. Lock et al., FROM TOXICOLOGICAL PROBLEM TO THERAPEUTIC USE - THE DISCOVERY OF THE MODE OF ACTION OF TRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE (NTBC), ITS TOXICOLOGY AND DEVELOPMENT AS A DRUG, Journal of inherited metabolic disease, 21(5), 1998, pp. 498-506
Authors:
GARDINER SM
AUTON TR
DOWNHAM MR
SHARP HL
KEMP PA
MARCH JE
RUSHTON A
BENNETT T
GLOVER JF
Citation: Sm. Gardiner et al., EFFECTS OF ACTIVE IMMUNIZATION AGAINST ANGIOTENSIN PEPTIDES ON THE PRESSOR EFFECTS EXOGENOUS ANGIOTENSIN-I (AI) IN CONSCIOUS RATS, British Journal of Pharmacology, 124, 1998, pp. 119-119
Citation: Rp. Mee et al., DESIGN OF ACTIVE ANALOGS OF A 15-RESIDUE PEPTIDE USING D-OPTIMAL DESIGN, QSAR AND A COMBINATORIAL SEARCH ALGORITHM, The journal of peptide research, 49(1), 1997, pp. 89-102
Authors:
ELDRIDGE MD
MURRAY CW
AUTON TR
PAOLINI GV
MEE RP
Citation: Md. Eldridge et al., EMPIRICAL SCORING FUNCTIONS .1. THE DEVELOPMENT OF A FAST EMPIRICAL SCORING FUNCTION TO ESTIMATE THE BINDING-AFFINITY OF LIGANDS IN RECEPTOR COMPLEXES, Journal of computer-aided molecular design, 11(5), 1997, pp. 425-445
Authors:
MURRAY CW
CLARK DE
AUTON TR
FIRTH MA
LI J
SYKES RA
WASZKOWYCZ B
WESTHEAD DR
YOUNG SC
Citation: Cw. Murray et al., PRO-SELECT - COMBINING STRUCTURE-BASED DRUG DESIGN AND COMBINATORIAL CHEMISTRY FOR RAPID LEAD DISCOVERY .1. TECHNOLOGY, Journal of computer-aided molecular design, 11(2), 1997, pp. 193-207
Authors:
ELLIS MK
WHITFIELD AC
GOWANS LA
AUTON TR
PROVAN WM
LOCK EA
LEE DL
SMITH LL
Citation: Mk. Ellis et al., CHARACTERIZATION OF THE INTERACTION OF ZOYL]-4,4,6,6-TETRAMETHYL-CYCLOHEXANE-1,3,5-TRIONE WITH RAT HEPATIC 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE, Chemical research in toxicology, 9(1), 1996, pp. 24-27
Citation: Aj. Deavin et al., STATISTICAL COMPARISON OF ESTABLISHED T-CELL EPITOPE PREDICTORS AGAINST A LARGE DATABASE OF HUMAN AND MURINE ANTIGENS, Molecular immunology, 33(2), 1996, pp. 145-155
Citation: Pmd. Foster et Tr. Auton, APPLICATION OF BENCHMARK DOSE RISK ASSESSMENT METHODOLOGY TO DEVELOPMENTAL TOXICITY - AN INDUSTRIAL VIEW, Toxicology letters, 82-3, 1995, pp. 555-559
Citation: Tr. Auton et al., RETROSPECTIVE APPRAISAL OF THE RELATIONSHIP BETWEEN SKIN IRRITANCY AND CONTACT SENSITIZATION POTENTIAL, Journal of toxicology and environmental health, 46(2), 1995, pp. 149-154
Authors:
ELLIS MK
WHITFIELD AC
GOWANS LA
AUTON TR
PROVAN WM
LOCK EA
SMITH LL
Citation: Mk. Ellis et al., INHIBITION OF 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE BY RO-4-TRIFLUOROMETHYLBENZOYL)-CYCLOHEXANE-1,3-DIONE AND RO-4-METHANESULFONYLBENZOYL)-CYCLOHEXANE-1,3-DIONE, Toxicology and applied pharmacology, 133(1), 1995, pp. 12-19
Authors:
AUTON TR
WESTHEAD DR
WOOLLEN BH
SCOTT RC
WILKS MF
Citation: Tr. Auton et al., A PHYSIOLOGICALLY-BASED MATHEMATICAL-MODEL OF DERMAL ABSORPTION IN MAN, Human & experimental toxicology, 13(1), 1994, pp. 51-60
Authors:
HILTON J
WOOLLEN BH
SCOTT RC
AUTON TR
TREBILCOCK KL
WILKS MF
Citation: J. Hilton et al., VEHICLE EFFECTS ON IN-VITRO PERCUTANEOUS-ABSORPTION THROUGH RAT AND HUMAN SKIN, Pharmaceutical research, 11(10), 1994, pp. 1396-1400
Citation: Jd. Ramsey et al., THE PREDICTIVE ACCURACY OF IN-VITRO MEASUREMENTS FOR THE DERMAL ABSORPTION OF A LIPOPHILIC PENETRANT (FLUAZIFOP-BUTYL) THROUGH RAT AND HUMAN SKIN, Fundamental and applied toxicology, 23(2), 1994, pp. 230-236
Citation: Tr. Auton et al., MODELING DERMAL PHARMACOKINETICS USING INVITRO DATA .1. FLUAZIFOP-BUTYL IN THE RAT, Human & experimental toxicology, 12(3), 1993, pp. 199-206
Citation: Tr. Auton et al., MODELING DERMAL PHARMACOKINETICS USING INVITRO DATA .2. FLUAZIFOP-BUTYL IN MAN, Human & experimental toxicology, 12(3), 1993, pp. 207-213
Citation: Tr. Auton, CONCENTRATION FLUX RELATIONS FOR A MULTICELLULAR BIOLOGICAL MEMBRANE WITH METABOLISM, Mathematical biosciences, 115(1), 1993, pp. 103-117